PFIZER INC — Director's Dealing 2009

Nov 3, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2009-10-30

Reporting Person: Dolsten Mikael (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-10-30	Common Stock	A	58720	—	Acquired	58720	Direct
2009-10-30	Common Stock	A	41104	—	Acquired	99824	Direct

Footnotes

F1: The reported transaction constitutes the grant of restricted stock units, which will vest and be settled in shares of Pfizer common stock on the third anniversary of the date of grant, provided that Dr. Dolsten remains in the continuous employ of Pfizer until that anniversary date. This grant was made in connection with Dr. Dolsten's election as Pfizer's Senior Vice President; President - BioTherapeutics Research & Development effective October 16, 2009.

F2: The reported transaction constitutes the grant of restricted stock units, which will vest and be settled in shares of Pfizer common stock on the third anniversary of the date of grant, provided that Dr. Dolsten remains in the continuous employ of Pfizer until that anniversary date. This grant represents a portion of Dr. Dolsten's Executive Long-Term Incentive Program Award for 2010.